NH, L., J, S., PM, V., & BL, S. (2022). Trends and costs of stereotactic body radiation therapy in metastatic non-small cell lung cancer. Journal of thoracic disease, 14(7), 2579. https://doi.org/10.21037/jtd-21-1835
Chicago Style (17th ed.) CitationNH, Lester-Coll, Skelly J, Vacek PM, and Sprague BL. "Trends and Costs of Stereotactic Body Radiation Therapy in Metastatic Non-small Cell Lung Cancer." Journal of Thoracic Disease 14, no. 7 (2022): 2579. https://doi.org/10.21037/jtd-21-1835.
MLA (9th ed.) CitationNH, Lester-Coll, et al. "Trends and Costs of Stereotactic Body Radiation Therapy in Metastatic Non-small Cell Lung Cancer." Journal of Thoracic Disease, vol. 14, no. 7, 2022, p. 2579, https://doi.org/10.21037/jtd-21-1835.
Warning: These citations may not always be 100% accurate.